As our research programme develops, this page will provide more details about the portfolio of CanTest projects. In order to form part of the programme, projects must be approved via a two-stage scientific peer review process. This includes assessment against the following principles:
- The current diagnostic process in primary care is a problem;
- Improving the triaging and diagnostic process related to (1) may have value to patients and society by having a potential impact on the morbidity, mortality, patient experience or healthcare utilisation of patients with and without cancer;
- There is at least promising evidence from Phase 1 or later phases of the CanTest Framework, or research from other settings;
- The diagnostic process is potentially feasible in community or primary care settings.
Below you can find out more information about our current projects:
Can dermoscopy be used accurately and effectively in primary care to improve the timely diagnosis of melanoma ?
A systematic review of existing research focusing on whether dermoscopes, with suitable training, can be used accurately and effectively by GPs, to improve early diagnosis of melanoma. Read more
Magnetic resonance imaging (MRI) for prostate cancer diagnosis in primary care
This PhD project will explore a number of areas relating to whether it would be safe, acceptable, and cost effective for GPs to order MRI scans for men with symptoms suggesting a possible diagnosis of prostate cancer. Read more
Establishing the diagnostic accuracy of haemoglobin in faecal immunochemical tests (FITs) in the primary care symptomatic population: a multicentre cohort study
This project will collect data to see how well FITs perform at diagnosing colorectal cancer in the primary care population, and to recommend a Hb level for further diagnostic testing when patients have a positive FIT. Read more
Understanding missed diagnostic opportunities in bladder and kidney cancer
This PhD project will use bladder and kidney cancer as exemplars to identify missed diagnostic opportunities in early cancer diagnosis.
What is the clinical-effectiveness and cost-effectiveness of embedded risk-of-cancer assessment of patients in primary care: the ERICA trial
This is a cluster-randomised controlled trial of electronic clinical decision support in 710 English general practices. Read more